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Heparin-Binding EGF-Like Growth Factor
Promotes Epithelial–Mesenchymal Transition
in Human Keratinocytes
Stefan W. Stoll1, Laure Rittie´1, Jessica L. Johnson1 and James T. Elder1,2
We have shown that autocrine proliferation of human keratinocytes (KCs) is strongly dependent upon
amphiregulin (AREG), whereas blockade of heparin-binding EGF-like growth factor (HB-EGF) inhibits KC
migration in scratch wound assays. Here we demonstrate that expression of soluble HB-EGF (sHB-EGF) or full-
length transmembrane HB-EGF (proHB-EGF), but not proAREG, results in profound increases in KC migration
and invasiveness in monolayer culture. Coincident with these changes, HB-EGF significantly decreases mRNA
expression of several epithelial markers including keratins 1, 5, 10, and 14 while increasing expression of
markers of cellular motility including SNAI1, ZEB1, COX-2, and MMP1. Immunostaining revealed HB-EGF-
induced expression of the mesenchymal protein vimentin and decreased expression of E-cadherin, as well as
nuclear translocation of b-catenin. Suggestive of a trade-off between KC motility and proliferation,
overexpression of HB-EGF also reduced KC growth by 490%. We also show that HB-EGF is strongly induced
in regenerating epidermis after partial-thickness wounding of human skin. Taken together, our data suggest that
expression of HB-EGF in human KCs triggers a migratory and invasive phenotype with many features of
epithelial–mesenchymal transition (EMT), which may be beneficial in the context of cutaneous wound healing.
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INTRODUCTION
Heparin-binding EGF-like growth factor (HB-EGF) is one of
the seven ligands that bind to and activate the EGFR, also
known as ErbB1 (Sanderson et al., 2006). HB-EGF was
originally isolated from macrophage-like U937 cells as a
secreted 22-kDa heparin-binding growth factor with mitotic
activity for BALB-3T3 fibroblasts and smooth muscle cells
(Higashiyama et al., 1991). Although the precursor of HB-
EGF (proHB-EGF) is a transmembrane protein that functions
as the diphtheria toxin receptor (Naglich et al., 1992), its
proteolytic cleavage by metalloproteinases (MPs) generates
soluble HB-EGF (sHB-EGF) (Sanderson et al., 2006), as well
as a carboxy-terminal domain, which can bind to the nuclear
proteins promyelocytic leukemia zinc-finger protein (PLZF)
and Bcl-6 (Nanba et al., 2003; Kinugasa et al., 2007).
HB-EGF is an important factor in wound healing (Mar-
ikovsky et al., 1993; Stoll et al., 1997; Tokumaru et al., 2000;
Shirakata et al., 2005; Mathay et al., 2008), atherosclerosis
(Nakata et al., 1996), blastocyst implantation (Das et al.,
1994), and cardiac development and function (Iwamoto et al.,
2003; Jackson et al., 2003; Yamazaki et al., 2003). Increased
expression of HB-EGF has been found in multiple cancers
including hepatocellular, pancreatic, gastric, and breast
cancer, as well as in squamous cell carcinoma of the skin
(Raab and Klagsbrun, 1997; Rittie´ et al., 2007). Together with
amphiregulin (AREG), epiregulin (EREG), and transforming
growth factor-a, HB-EGF is produced and secreted by normal
human keratinocytes (NHKs; Stoll et al., 2010a) and acts as an
autocrine growth factor in these cells (Coffey et al., 1987;
Cook et al., 1991; Hashimoto et al., 1994; Shirakata et al.,
2000). Similar to AREG, HB-EGF contains a heparin-binding
domain immediately upstream of the conserved EGF motif
(Sanderson et al., 2006). Unlike AREG, but similar to
betacellulin and EREG, HB-EGF can also bind ErbB4,
another member of the EGFR family (Elenius et al., 1997).
However, in keratinocytes (KCs) and skin, HB-EGF is likely
to exert its biological function via binding to EGFR because
KCs do not express ErbB4 (De Potter et al., 2001; Stoll
et al., 2001).
In human skin, expression of HB-EGF is relatively low, but
is increased in cutaneous wounds (McCarthy et al., 1996;
Stoll et al., 1997; Mathay et al., 2008) and in psoriasis (Stoll
and Elder, 1998). HB-EGF expression is also rapidly induced
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in the context of an EGFR-dependent injury response in
skin organ culture (Stoll et al., 1997, 2001). Furthermore,
HB-EGF expression in KCs is strongly increased by retinoids
(Stoll and Elder, 1998; Rittie´ et al., 2006) and by oxidative
stress and cholesterol depletion (Mathay et al., 2008; Giltaire
et al., 2011).
We have previously shown that AREG and HB-EGF have
distinct context-dependent functions in human KCs (Stoll
et al., 2010a). The aim of this paper was to investigate the
effect of HB-EGF overexpression in KC physiology in more
detail. Here we show that constitutive and conditional
lentivirus-mediated expression of HB-EGF in normal and
immortalized human KCs promotes profound morphological,
behavioral, and biochemical changes that display many
features of epithelial–mesenchymal transition (EMT). Indica-
tive of in vivo relevance, we also show that HB-EGF
expression is strongly upregulated in the regenerating
epidermis after partial-thickness wound in human skin.
RESULTS
To gain insight into the consequences of HB-EGF over-
expression in human KCs, we used previously established cell
lines with constitutive and tetracycline (TET)-inducible
expression of proHB-EGF or sHB-EGF and for purpose of
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Figure 1. Heparin-binding EGF-like growth factor (HB-EGF) overexpression strongly changes keratinocyte (KC) morphology. (a) N/TERT KCs with inducible
expression of HB-EGF were grown to B40% confluence and incubated for 60 hours with or without tetracycline (TET). Normalized HB-EGF mRNA levels
(*Po0.05, n¼ 3–6) and protein shedding (*Po0.0005, n¼ 3) into conditioned medium (CM) were analyzed by quantitative reverse transcriptase–PCR (QRT–PCR)
and ELISA, respectively. (b) N/TERT KCs with and without constitutive expression of proHB-EGF or proAREG. Treatment (tx) with recombinant human (rh)HB-EGF
or EGF was for 72hours. (c) N/TERT KCs were exposed to CM from N/TERT or cells expressing His-tagged soluble (s)HB-EGF for 72hours with and without prior
depletion of sHB-EGF using nickel affinity chromatography. (d) N/TERT KCs with inducible expression of sHB-EGF or proHB-EGF were incubated in the presence
or absence of TET with and without 10mgml–1 HB-EGF antibodies (Abs), 1mM PD158780, or 40mM GM6001 for 1–3 days. Bar¼ 200mm.
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comparison with stable expression of proAREG or sAREG
(Stoll et al., 2010a). Because of the limited lifespan of NHKs,
we used N/TERT-2G cells, an immortalized but nontrans-
formed KC cell line (Dickson et al., 2000), in order to
establish stable cell lines. An overview of the various
complementary DNA constructs used to generate these lines
is shown in Supplementary Figure S1 online.
As demonstrated with the inducible cell lines in Figure 1a,
HB-EGF mRNA and secreted protein were strongly induced
in N/TERT KCs after TET treatment. Overexpression of HB-
EGF in KCs led to marked morphological and cellular
changes. As shown in Figure 1b, stably selected N/TERT
KCs with constitutive expression of proHB-EGF displayed a
high degree of cell scattering, with most KCs assuming an
elongated, spindle-shaped morphology. These changes were
observed in a total of eight stably selected KC cell lines with
either constitutive or conditional expression of proHB-EGF
or sHB-EGF (see also Supplementary Figure S2 online). In
contrast, AREG-infected N/TERT KCs exhibited cobblestone
morphology with cell colonies growing as continuous
epithelial sheet very similar to uninfected N/TERT controls.
Notably, incubation of KCs with various concentrations of
recombinant human HB-EGF or EGF (Figure 1b) could not
fully reproduce the phenotype observed in HB-EGF-expres-
sing KC cell lines. In contrast, exposure of N/TERT KCs to
conditioned medium (CM) from cells expressing His-tagged
HB-EGF reproduced the phenotypic changes observed in HB-
EGF-expressing KC cell lines, unless HB-EGF was depleted
from CM before exposure (Figure 1c). Phenotypic changes
similar to those in N/TERT were also observed in NHKs after
transient infection with HB-EGF-encoding lentiviruses (Sup-
plementary Figure S3 online).
We next examined whether neutralization of HB-EGF,
EGFR, or MP activity could prevent the effects on cell
scattering and morphology (Figure 1d). As expected, the
EGFR family (ErbB) receptor tyrosine kinase inhibitor (RTKI)
PD158780 strongly reversed HB-EGF-induced cell scattering.
Interestingly, HB-EGF-neutralizing antibodies and the MP
inhibitor GM6001 prevented HB-EGF-induced cell scattering
in KCs expressing proHB-EGF, but not in cells expressing
sHB-EGF (Figure 1d).
To examine whether there were differences in motility
between AREG- and HB-EGF-overexpressing KCs, we
performed time-lapse microscopy experiments (see Supple-
mentary Data/Videos online). Our results show that AREG-
infected KCs moved as a continuous cell sheet in a manner
Figure 2. Heparin-binding EGF-like growth factor (HB-EGF) expression
strongly reduces keratinocyte (KC) cell numbers in vitro. N/TERT KCs with
inducible expression of HB-EGF were plated and incubated with or without
tetracycline (TET). (a, b) Time course of KC growth with and without HB-EGF
expression (with or without TET). Day 0 denotes the time of TET treatment.
Cells were fixed and stained with (a) crystal violet, and (b) absorption at
590 nm was measured after extraction of crystal violet with 10% acetic
acid; mean±SEM, n¼4 except day 0 and day 6, n¼ 2; *Po0.05 and
**Po0.00001 (two-tailed Student’s t-test). (c) N/TERT KCs were incubated
with or without TET for 6 days, and after trypsinization cell number
was determined by hemocytometer counting. Data are expressed as
percent of control, mean±SEM, n¼ 6 for soluble (s)HB-EGF (Po0.0001,
two-tailed Student’s t-test) and n¼2 for precursor of HB-EGF (proHB-EGF).
Representative photos at day 6 are shown below the graph. Bar¼ 200mm.
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very similar to uninfected N/TERT KCs. In marked contrast,
HB-EGF-overexpressing cells were much more motile and
less adherent to their neighboring cells, with highly elongated
cells unable to maintain cell–cell contacts (see Supplemen-
tary Data and Videos S1–S3 online).
To test the effect of HB-EGF overexpression on KC growth,
we performed growth assays with the TET-regulated HB-EGF
cell lines. As demonstrated in Figure 2, forced HB-EGF
expression (þTET) strongly reduced KC growth relative to
control cells (TET). A marked and significant reduction of
KC growth was evident as early as 2 days after HB-EGF
induction (Figure 2a and b). At 6 days after induction of
HB-EGF expression, KC growth was reduced by 490%
compared with control cells (Figure 2c). In contrast, TET
treatment had no effect on KC growth in control cells
(N/TERT-TR, Supplementary Figure S4 online).
The marked phenotypic changes observed in HB-EGF-
infected cells including increased migration, scattering, and
elongation in cell shape are characteristic of cells undergoing
EMT (Lee et al., 2006; De Wever et al., 2008). We therefore
tested whether HB-EGF-overexpressing cells display other
features of this process including increased expression of
the mesenchymal protein vimentin, decreased expression
of E-cadherin, and intracellular redistribution of b-catenin
(Lee et al., 2006; De Wever et al., 2008). As shown in
Figure 3a, vimentin was strongly expressed in KCs
with constitutive overexpression of proHB-EGF but not in
proAREG-expressing KCs or control cells. Moreover,
vimentin staining was strongly reduced in the presence of
PD158780. Addition of high concentrations of exogenous
EGF increased vimentin expression in a subset of N/TERT
KCs, although to a much lesser extent than in HB-EGF-
overexpressing cells.
Constitutive overexpression of HB-EGF also led to marked
changes in the cellular distribution of b-catenin with
markedly decreased membrane staining and increased
nuclear staining, which was not observed in control N/TERT
or AREG-expressing cells (Figure 3b). Nuclear accumulation
of b-catenin in HB-EGF-expressing but not in control cells
was also confirmed by western blotting of nuclear extracts.
Treatment of N/TERT-HB-EGF KCs with the ErbB RTKI
PD158780 preserved cell surface staining and prevented
the nuclear localization of b-catenin (Figure 3b). Similar to
the results for b-catenin, N/TERT control cells showed a
well-defined cell surface staining of the epithelial adherens
junction protein E-cadherin, which was strongly decreased
in response to HB-EGF overexpression or treatment
of control cells with 100 ngml–1 of exogenous EGF
for 24 hours (Figure 3c). As shown in Figure 4a, and in
agreement with a shift of HB-EGF-overexpressing KCs from
an epithelial to a more mesenchymal appearance, expres-
sion of several other epithelial cell–specific genes includ-
ing KRT1, KRT10, KRT5, and KRT14 was strongly reduced
in these cells.
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Figure 3. Heparin-binding EGF-like growth factor (HB-EGF) expression alters expression and cellular distribution of epithelial-mesenchymal transition-
related proteins in human keratinocytes (KCs). (a) HB-EGF induces vimentin protein expression in KCs. N/TERT KCs with constitutive expression of
amphiregulin (AREG) or HB-EGF were treated with and without EGF or PD158780 for 24 hours, and vimentin immunoreactivity was detected by fluorescence
microscopy. Nuclei were counterstained with 40,6-diamidino-2-phenylindole (DAPI). (b) HB-EGF expression in KCs leads to nuclear accumulation of b-catenin.
KCs were cultured in the presence or absence of EGF or PD158780. KCs were stained with b-catenin antibodies (Abs) and visualized by immunofluorescence
microscopy. Arrows indicate positive nuclear staining. The western blot demonstrates increased nuclear accumulation of b-catenin in HB-EGF-expressing cells.
(c) Immunofluorescence microscopy of E-cadherin staining in N/TERT KCs. Please note the membranous E-cadherin staining in control cells that is strongly
decreased in EGF-treated or HB-EGF-expressing cells. Bar¼50 mm.
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E-cadherin gene (CDH1) expression is regulated by several
transcriptional repressors, including members of the Snail,
Twist, and ZEB families (for review, see de Herreros et al.,
2010). As demonstrated in Figure 4b, and in agreement with
the decreased immunodetection of E-cadherin in N/TERT-
HBEGF KCs shown above, SNAI1 and ZEB1 transcript levels
were markedly increased in HB-EGF-overexpressing cells
relative to control N/TERT. Furthermore, expression of several
other genes that have been previously implicated in EMT and/
or tumor invasion, including COX-2, vimentin (VIM), and the
matrix metalloproteinases MMP1 and MMP10 (Lee et al.,
2006; Gupta et al., 2007; Uttamsingh et al., 2008; Bos et al.,
2009), was markedly upregulated in HB-EGF-expressing KCs
(Figure 4b).
To test whether the increased motility of HB-EGF-express-
ing cells coincides with an increased invasive capacity, we
tested them on Matrigel invasion assays. As can be seen in
Figure 5, HB-EGF-expressing cells showed a strongly in-
creased degree of invasiveness relative to control KCs. Indeed,
HB-EGF-overexpressing KCs were more invasive than the
metastatic breast cancer cell line MDA-MB231 (Shimizu
et al., 2002) and very similar to the human fibrosarcoma cell
line HT1080 (Kramer et al., 1986).
To better delineate the potential in vivo relevance of HB-
EGF in human skin wounding, we assessed the expression
of HB-EGF in the regenerating epidermis of carbon dioxide
laser-treated skin of human subjects by laser capture
microdissection. As shown in Figure 6, HB-EGF mRNA was
strongly upregulated by 1 week after laser injury, and
remained elevated for at least 4 weeks.
DISCUSSION
We have previously shown that AREG is essential for human
KC proliferation in vitro under autocrine and growth
factor–stimulated conditions (Stoll et al., 2010a, b). Here we
demonstrate that in contrast to the proliferative function
of AREG, overexpression of HB-EGF inhibits proliferation
(Figure 2) and promotes a migratory phenotype with
pronounced cell scattering and elongated, spindle-cell
morphology (Figure 1, Supplementary Video S3 and Supple-
mentary Data online). The observed morphological changes
characterized by the reduction of epithelial cell–cell adhesion
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Figure 4. Heparin-binding EGF-like growth factor (HB-EGF) overexpression strongly alters keratin and epithelial–mesenchymal transition/invasion-
related gene expression in human keratinocytes (KCs). N/TERT KCs were incubated in the presence or absence of tetracycline (TET) for 60 hours, and gene
expression was analyzed by quantitative reverse transcriptase–PCR (QRT–PCR). (a) Gene expression was analyzed with TaqMan assays specific for human
keratins as indicated. Data are expressed as percent of control (TET), mean±SEM, n¼ 3–6. The reduction was significant for all data points with Po0.005
versus controls except for the soluble (s)HB-EGF-induced reduction of keratin 14 (K14) mRNA expression (Po0.022) as assessed by two-tailed, one-sample
t-test. (b) HB-EGF increases invasion-related gene expression. Data are expressed as relative mRNA levels, mean±SEM, n¼ 3–6, *Po0.05, **Po0.005 vs.
control (TET).
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in combination with spindle-cell appearance are hallmarks of
EMT (Lee et al., 2006; De Wever et al., 2008). EMT has an
important role during embryonic development and is strongly
implicated in the early stages of carcinogenesis and in cancer
progression including invasion, metastasis, and recurrence
(De Wever et al., 2008). Our data show that HB-EGF-
overexpressing KCs have a strongly increased capacity for
three-dimensional invasion through Matrigel basement mem-
brane, which is very similar to the invasive fibrosarcoma cell
line HT1080 (Kramer et al., 1986; Figure 5).
In addition to the changes in phenotype and motility, our
results demonstrate that HB-EGF-overexpressing KCs display
many of the commonly described characteristics of EMT,
including decreased expression of E-cadherin, cellular redis-
tribution of b-catenin, and increased expression of vimentin
(Lee et al., 2006; Figure 3). We also found markedly
increased expression of several genes that have been
implicated in EMT and/or during tumor progression including
COX-2 (Tsujii et al., 1997; Gupta et al., 2007), MMP1, and
MMP10 (Gupta et al., 2007; Figure 4).
Several transcription factors have been identified as key
regulators of EMT including the transcriptional repressors
SNAI1, SNAI2, TWIST1, and ZEB1 (de Herreros et al., 2010).
These transcription factors have been shown to inhibit the
expression of E-cadherin and other epithelial cell junction
proteins that are important for the maintenance of the epithelial
architecture (Cano et al., 2000; Lee et al., 2006; Moreno-Bueno
et al., 2006; Olmeda et al., 2007; Peinado et al., 2007; de
Herreros et al., 2010). Here we show that HB-EGF over-
expression results in markedly increased expression of SNAI1
and ZEB1.
All EGFR ligands are produced as membrane-bound
precursors, which undergo proteolytic cleavage by MPs to
release soluble ligands, which bind to and activate ErbB
receptors (Sanderson et al., 2006). Recent findings suggest
important ErbB-independent roles of the intracellular do-
mains of these precursors in the regulation of cellular
functions (Nanba et al., 2003; Hirata et al., 2009; Stoeck
et al., 2010; Stoll et al., 2010b). In our study, sHB-EGF was as
effective as proHB-EGF in inducing EMT-like changes in KCs
(Figure 1 and Supplementary Figure S2 online), suggesting
that the intracellular domain of HB-EGF may be dispensable
for these effects, with the caveat that low levels of
endogenous HB-EGF might be sufficient to provide the
intracellular domain in sHB-EGF-expressing cells. In any
case, MP-mediated HB-EGF shedding is clearly necessary
for induction of EMT, because the MP inhibitor GM6001
efficiently blocked the phenotypic changes in proHB-EGF-
expressing cells, but not in sHB-EGF-expressing cells. The
ErbB RTKI PD158780 strongly blocked HB-EGF-induced
phenotypic changes, suggesting that activation of EGFR
and/or other ErbBs is necessary for EMT. This is in agreement
with findings in other epithelial systems, suggesting that
N/TERT N/TERT-sHB-EGF HT1080 MDA-MB231
Figure 5. Hypermotility and invasiveness as a function of heparin-binding EGF-like growth factor (HB-EGF) overexpression in human keratinocytes (KCs).
N/TERT KCs MDA-MB231 and HT1080 cells were seeded in serum-free medium on growth factor reduced Matrigel and incubated for 36 hours with serum-
containing media as a chemoattractant as described in Materials and Methods. Invading cells were stained with crystal violet and photographed. Photos
show representative fields; invasion assays with HT1080 and MDA-MB231 cells are shown for comparison. Results shown are representative of three
independent experiments; similar results as shown here for soluble (s)HB-EGF were also obtained with proHB-EGF (not shown). The typical cell morphology
of the various lines is shown in the panels above the invasion assay photos. Bar¼200 mm.
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Figure 6. Heparin-binding EGF-like growth factor (HB-EGF) expression in
human skin wounds. HB-EGF mRNA expression was analyzed by quantitative
reverse transcriptase–PCR (QRT–PCR) in regenerating interfollicular epidermis
isolated by laser capture microdissection from skin biopsies taken 1–4 weeks
after CO2 laser-generated partial-thickness wounds. Data are normalized to
the control gene RPLP0 (36B4) and are expressed as fold change (log-scale)
relative to unwounded skin, n¼ 6.
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activation of EGFR by HB-EGF is important for this process
(Yagi et al., 2008; Yin et al., 2010; Lue et al., 2011). Our data
also indicate that the HB-EGF antibody (Ab) we used is more
effective in neutralizing the motogenic activity of proHB-EGF
compared with sHB-EGF (Figure 1d). It is possible that this Ab
interferes with MP-mediated shedding of membrane-bound
proHB-EGF, as previously suggested for other HB-EGF Abs
(Hamaoka et al., 2010).
It was surprising that relatively small amounts of HB-
EGF (o1ngml–1) detected by ELISA in KC CM (Figure 1a)
could account for the pronounced EMT-like changes we
observed, especially when compared with much higher
concentrations of exogenously added recombinant human
(rh)HB-EGF (10 or 100 ngml–1; Figure 1b). Our data also
demonstrate that the motogenic effects of overexpressed sHB-
EGF are directly due to shed HB-EGF, as removal of His-
tagged sHB-EGF from KC CM by nickel chromatography
completely abolishes its motogenic effect (Figure 1c). Taken
together, these results suggest that KC-derived HB-EGF is
considerably more potent than rhHB-EGF, possibly due
to differences in proteolytic processing or posttranslational
modification.
Normal and immortalized KCs shed roughly 10 times
more AREG (5–10 ngml–1; Stoll et al., 2010a) than the low
levels of HB-EGF (o1ngml–1) that we observed in these
experiments (Figure 1a). Moreover, the concentration of shed
AREG is increased even further in HB-EGF-overexpressing
cells (Supplementary Figure S5 online). Surprisingly, despite
this increase in AREG concentration, HB-EGF overexpression
led to a large decrease in KC growth (Figure 2). Because HB-
EGF has a higher affinity for EGFR than AREG (Kochupur-
akkal et al., 2005), it is possible that this outcome is due to
receptor occupancy and/or downregulation by HB-EGF. This
could also explain the relatively small amount of sHB-EGF
detected in KC CM (Figure 1a). However, because KCs prefer
to proliferate as colonies rather than individual cells
(Rheinwald and Green, 1977), we suspect that the EMT-like
changes induced by HB-EGF inhibit KC growth by diminish-
ing cell–cell contact.
Although these experiments have been conducted in
cultured cells, several lines of evidence indicate that our
results are relevant to the in vivo situation. HB-EGF has been
implicated in promoting metastasis of other epithelial cell
types in vivo (Yagi et al., 2008; Yin et al., 2010; Lue et al.,
2011). In addition, we and others have previously shown that
HB-EGF is overexpressed in nonmelanoma skin cancers
(Raab and Klagsbrun, 1997; Rittie´ et al., 2007) and in
retinoid-treated human skin (Stoll and Elder, 1998; Rittie´
et al., 2006). In normal skin, HB-EGF has been implicated in
the process of re-epithelialization, during which KCs must
rapidly migrate to cover the wound bed (Hashimoto et al.,
1994; Tokumaru et al., 2000). We have previously shown
that HB-EGF is rapidly induced in short-term organ cultures
of human skin, followed later by AREG and transforming
growth factor-a (Stoll et al., 1997). Here we show that HB-
EGF is also strongly induced in healing human epidermis
after laser-induced partial-thickness skin wounding in vivo
(Figure 6). Interestingly, we found that overexpression of
HB-EGF in KCs is accompanied by markedly decreased expres-
sion of keratins 5, 14, 1, and 10 (Figure 4). The somewhat
stronger inhibition of keratins 1 and 10 relative to keratins 5 and
14 by HB-EGF is in agreement with a previous report that these
differentiation-related keratins are strongly suppressed by inclu-
sion of EGF in the culture medium (Poumay and Pittelkow,
1995). On the basis of these findings, we propose that the role of
HB-EGF in re-epithelializing wounds is to induce KC migration
while inhibiting proliferation and differentiation.
In summary, our data demonstrate that HB-EGF over-
expression induces an EMT-like phenotype of highly motile
KCs with markedly increased invasive potential. These data
implicate HB-EGF as a potential mediator of the molecular
mechanisms that control EMT and invasiveness in otherwise
normal KCs, and as such it is an attractive potential target for
therapeutic exploration.
MATERIALS AND METHODS
Reagents
The metalloproteinase inhibitors GM6001 and the ErbB RTKI
PD158780 were purchased from Calbiochem (San Diego, CA).
EGF was from Peprotech (Rocky Hill, NJ) and recombinant human
HB-EGF and HB-EGF Ab were from R&D Systems (Minneapolis,
MN). Other Abs used in this study were mouse anti-Vimentin (Clone
V9, Chemicon, Temecula, CA), rat anti-E-Cadherin (Clone ECCD-2,
Invitrogen, Carlsbad, CA), and the anti-b-catenin mAb (clone
15B8, Sigma-Aldrich, St Louis, MO). Horseradish peroxidase- or
FITC-conjugated secondary Abs were purchased from Upstate
Biotechnology (Lake Placid, NY) or ICN (Costa Mesa, CA).
Ni-NTA agarose, antibiotics, and Lipofectamine 2000 were
obtained from Invitrogen. All other chemicals included were
from Sigma-Aldrich.
In vivo wound healing studies
All procedures involving human subjects were approved by the
Institutional Review Board of the University of Michigan and
conducted according to the Declaration of Helsinki Principles.
Written, informed consent was obtained from all participants prior
to enrollment in the study. All methods have been described
previously (Rittie´ et al., 2011). Briefly, partial-thickness wounds
were performed on forearm skin using a CO2 laser, which removed
the entire epidermis and papillary dermis. Wounds were dressed
until re-epithelialization was visually achieved (10–14 days). Full-
thickness biopsies (4mm) were taken in the center of wounded
areas 1–4 weeks after laser treatment, and in an adjacent area for
control. Frozen sections were prepared and interfollicular epider-
mis was isolated from the dermis and hair follicle infundibula by
laser capture microdissection. Total RNA was extracted from
microdissected tissue and reverse-transcribed in complementary
DNA, which was in turn preamplified and analyzed for HB-EGF
and 36B4 expression by quantitative reverse transcriptase–PCR with
custom primers and probe sets (Rittie´ et al., 2006).
Cell culture
N/TERT-2G, an immortalized, nontransformed KC cell line, was
grown in KC serum-free medium (KSFM, Gibco, Grand Island, NY)
as previously described (Dickson et al., 2000). NHKs were cultured
in serum-free medium (Medium 154 CF, Cascade Biologics, Portland,
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OR) with 0.1mM calcium (Stoll et al., 2001). MDA-MB231, HT1080,
and human embryonic kidney cells (293FT, Invitrogen) were grown
in DMEM (Gibco) with 10% fetal bovine serum (Atlanta Biologicals,
Lawrenceville, GA). For time-lapse microscopy, KC cell lines were
incubated in basal KSFM medium 4hours before the time-lapse
experiment and filmed for 16 hours with photographs taken every
5minutes.
Lentivirus-mediated gene expression
Complementary DNAs encoding the pro- or soluble forms of HB-
EGF and AREG were cloned into the lentiviral expression vectors
pLenti6/CMV/V5-DEST or pLenti4/TO/V5-DEST and used for lenti-
virus production in 293FT cells. Lentiviruses were used to transiently
infect NHKs or to generate stably transduced N/TERT KC cell lines
with constitutive or TET-inducible expression of AREG or HB-EGF as
previously described (Stoll et al., 2010a).
RNA isolation and quantitative reverse transcriptase–PCR
RNA isolation, reverse transcription, and quantitative reverse
transcriptase–PCR with predesigned TaqMan gene expression assays
(Applied Biosystems, Foster City, CA) were performed as previously
described (Stoll et al., 2010a). Gene expression data are expressed as
percent of the control gene RPLP0 (36B4) (Laborda, 1991; fold
change relative to 36B4, ¼ 2(CT targetCT 36B4) 100).
Cell growth assays
KCs were plated at 2,500 cells cm–2 in KSFM and allowed to attach
for 20 hours followed by incubation in the presence or absence of
1mgml–1 TET with medium changes every 2 to 3 days. KC cell
numbers were assessed by trypsinization followed by hemocyto-
meter counting, or after staining with crystal violet, and imaging. For
quantification of cell growth, crystal violet–stained cells were
incubated with 10% acetic acid for 5minutes, followed by
measurement of absorbance at 590 nm.
Nuclear isolation and western blotting
KCs were grown to 40–50% confluence in regular growth medium,
and deprived of growth factors by incubation in basal medium
for 48 hours. The cells were then incubated in fresh M154 in
the presence or absence of PD158780 (1 mM) or blocking Abs
directed against AREG or HB-EGF (5 mgml–1 each) and processed
for nuclear isolation as previously described (Stoll et al., 1998). Equal
amounts of protein were subjected to western blotting, as previously
described (Stoll et al., 2001), with the b-catenin primary Ab.
Immunofluorescence
KCs were plated (5,000 cells cm–2) and grown on coverslips until
B40% confluent, followed by incubation in basal M154 medium in
the presence or absence of inhibitors with and without EGF as
described above. Immunofluorescence staining was carried out as
previously described (Stoll et al., 2001) using the FITC-conjugated
secondary IgG Abs listed above. Nuclei were counterstained with
40,6-diamidino-2-phenylindole.
ELISA
Shed HB-EGF in KC CM were measured in duplicates by
sandwich ELISA (R&D Systems) according to the manufacturer’s
instructions.
Matrigel invasion assays
Growth factor reduced Matrigel Invasion Chambers (24-well plates
with 8mm pore size) were rehydrated according to the manufac-
turer’s instruction (BD Bioscience, Bedford, MA). Cells were plated
at 5 104 cells per insert in KSFM for KCs or DMEM for HT1080 and
MDA-MB231 cells. Fetal bovine serum (10%) was added as a
chemoattractant to the corresponding medium in the lower
chamber. Noninvading cells on the upper side of the membrane
were removed by scrubbing with cotton-tipped applicators, followed
by staining of invading cells on the lower side of the membrane with
crystal violet.
Statistical analysis
Statistical significance was determined by paired or unpaired
Student’s t-tests or one-sample t-tests as indicated in the figure
legends. Data are expressed as mean±SEM.
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